Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 28, 2009; 15(48): 6068-6074
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6068
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6068
Lipid name | Fold (IBS/healthy control) | P value1 | FDR Q value |
Cer (d18:1/24:1) | 1.3 | 0.001 | 0.022 |
Cer (d18:1/24:2) | 1.4 | 0.00004 | 0.0018 |
DG (36:2) | 1.9 | 0.000001 | 0.0003 |
GlycoSL (m/z = 1199.805) | 1.9 | 0.001 | 0.018 |
GlycoSL (m/z = 1195.851) | 2.0 | 0.0003 | 0.0069 |
lysoPC (16:0) | 2.1 | 0.00006 | 0.0020 |
lysoPC (18:0) | 1.9 | 0.0002 | 0.0049 |
lysoPC (18:1) | 2.8 | 0.00002 | 0.0013 |
lysoPE (18:1e) | 2.4 | 0.00002 | 0.0013 |
7TG (46:5) | 1.4 | 0.04 | 0.19 |
TG (48:5) | 1.6 | 0.03 | 0.17 |
TG (48:6) | 1.7 | 0.03 | 0.18 |
TG (49:3) | 2.1 | 0.009 | 0.089 |
TG (51:4) | 1.6 | 0.04 | 0.19 |
TG (51:5) | 1.8 | 0.02 | 0.12 |
- Citation: Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Orešič M, Korpela R. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 2009; 15(48): 6068-6074
- URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6068.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.6068